You are here: Industry Insights > Fast Track

News List

NeuroVive's NeuroSTAT Project Receives FDA Fast Track Designation prnasia
August 06, 2019
NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the company's candidate drug NeuroSTAT, in development for treatment of moderate to ...
NeuroSTAT Project Receives FDA Fast Track Designation americanpharmaceuticalreview
July 30, 2019
NeuroVive announced the company's candidate drug NeuroSTAT, in development for treatment of moderate to severe traumatic brain injury, TBI, has received Fast Track designation from the US Food and Drug Administration ...
AMAG Acquires Perosphere contractpharma
December 17, 2018
AMAG Pharmaceuticals has entered into a definitive agreement to acquire Perosphere Pharmaceuticals Inc.
FDA Grants Fast Track Designation to the Baricitinib Development Program americanpharmaceuticalreview
December 14, 2018
Eli Lilly and Company and Incyte announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to baricitinib......
Stealth BioTherapeutics Granted Fast Track Designation for Elamipretide americanpharmaceuticalreview
December 11, 2018
Stealth BioTherapeutics announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for its lead investigational candidate, elamipretide....
Vicinium Granted Fast Track Designation by FDA americanpharmaceuticalreview
August 13, 2018
Sesen Bio announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Vicinium for the treatment of BCG-unresponsive high-grade non-muscle invasive bladder cancer (NMIBC). Vicinium......
FDA places PaxVax's phase 2 chikungunya shot on its fast track fiercevaccines
May 17, 2018
Working against a disease with no available vaccines, PaxVax has picked up an important regulatory boost from the FDA for its chikungunya shot.